These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 31845630)

  • 21. An Overview on Bacteriophages: A Natural Nanostructured Antibacterial Agent.
    Rastogi V; Pragya ; Verma N; Mishra AK; Nath G; Gaur PK; Verma A
    Curr Drug Deliv; 2018; 15(1):3-20. PubMed ID: 27048165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy.
    Azam AH; Tanji Y
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2121-2131. PubMed ID: 30680434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phage therapy: a realistic weapon against multidrug resistant bacteria].
    Dufour N; Debarbieux L
    Med Sci (Paris); 2017 Apr; 33(4):410-416. PubMed ID: 28497737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.
    Aranaga C; Pantoja LD; Martínez EA; Falco A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.
    Khan AA; Manzoor KN; Sultan A; Saeed M; Rafique M; Noushad S; Talib A; Rentschler S; Deigner HP
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage Therapy for Multi-Drug Resistant Respiratory Tract Infections.
    Iszatt JJ; Larcombe AN; Chan HK; Stick SM; Garratt LW; Kicic A
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phage therapy, an alternative to antibiotic therapy?)].
    Reina J; Reina N
    Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phages and their potential to modulate the microbiome and immunity.
    Federici S; Nobs SP; Elinav E
    Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacteriophage therapy].
    Cold F; Olsen NS; Djurhuus AIMSM; Hansen LH
    Ugeskr Laeger; 2020 Jun; 182(27):. PubMed ID: 32594993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical application of bacteriophages for treatment of wound infections.
    Chang RYK; Morales S; Okamoto Y; Chan HK
    Transl Res; 2020 Jun; 220():153-166. PubMed ID: 32268129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outside-host phage therapy as a biological control against environmental infectious diseases.
    Merikanto I; Laakso JT; Kaitala V
    Theor Biol Med Model; 2018 Jun; 15(1):7. PubMed ID: 29879998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback?
    Hill C; Mills S; Ross RP
    Future Microbiol; 2018 May; 13():711-726. PubMed ID: 29792526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review.
    Lin J; Du F; Long M; Li P
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage-Based Applications in Synthetic Biology.
    Lemire S; Yehl KM; Lu TK
    Annu Rev Virol; 2018 Sep; 5(1):453-476. PubMed ID: 30001182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.